4/15
02:01 am
nnvc
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/7
02:09 am
nnvc
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/30
02:05 am
nnvc
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/22
02:04 am
nnvc
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/14
02:02 am
nnvc
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/6
02:04 am
nnvc
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/27
02:03 am
nnvc
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Neutral
Report
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/19
02:06 am
nnvc
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/15
06:46 am
nnvc
NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon [Yahoo! Finance]
Medium
Report
NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon [Yahoo! Finance]
2/15
06:30 am
nnvc
NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon
Medium
Report
NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon
2/11
01:00 am
nnvc
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/3
01:06 am
nnvc
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/1
06:40 am
nnvc
Clinical Trial Demonstration of Safety and Tolerability of NV-CoV-2 Has Implications Beyond COVID Treatment, Explains NanoViricides - NV-387 Could be As Revolutionary as Antibiotics [Yahoo! Finance]
Medium
Report
Clinical Trial Demonstration of Safety and Tolerability of NV-CoV-2 Has Implications Beyond COVID Treatment, Explains NanoViricides - NV-387 Could be As Revolutionary as Antibiotics [Yahoo! Finance]
2/1
06:20 am
nnvc
Clinical Trial Demonstration of Safety and Tolerability of NV-CoV-2 Has Implications Beyond COVID Treatment, Explains NanoViricides - NV-387 Could be As Revolutionary as Antibiotics
Low
Report
Clinical Trial Demonstration of Safety and Tolerability of NV-CoV-2 Has Implications Beyond COVID Treatment, Explains NanoViricides - NV-387 Could be As Revolutionary as Antibiotics
1/29
06:44 am
nnvc
Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found [Yahoo! Finance]
Low
Report
Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found [Yahoo! Finance]
1/29
06:30 am
nnvc
Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found
High
Report
Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found
1/26
01:45 am
nnvc
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.